CFB OPHTH02 Ocular Manifestations Of Systemic Disease
Ocular manifestations of systemic disease refer to the eye findings—such as retinopathy, uveitis, optic neuropathy, or vascular changes—that arise as complications of underlying systemic conditions including diabetes, hypertension, autoimmune disorders, and infections.
Ocular Manifestations of Systemic Disease
This lecture, delivered by Dr. Kendrick Shih, centres on one crucial concept: the retina provides a directly visible microvascular bed, making fundoscopy a window into systemic vascular health. The lecture focuses on three retinal manifestations:
- Diabetic Retinopathy — the most frequent cause of preventable blindness in working-aged adults
- Hypertensive Retinopathy — retinal arteriolar and neuroretinal signs associated with chronic or acutely severe hypertension
- Retinal Vein Occlusion — a multifactorial retinal vascular occlusion strongly associated with age and cardiovascular risk factors
The exam loves this lecture because it bridges medicine and ophthalmology: you must understand the systemic disease (DM, HTN) to interpret the fundoscopic signs, and you must recognize the fundoscopic signs to diagnose/stage the systemic disease. Past papers have tested diabetic retinopathy classification, hypertensive retinopathy grading, hydroxychloroquine maculopathy (SLE context), and Graves' ophthalmopathy — all fall under "ocular manifestations of systemic disease."
1. The Retina: Anatomy You Must Know for Fundoscopy
"The retina is the sensory portion of the eye and contains layers of photoreceptors, nerves, and supporting cells. The layer containing the ganglion cells, bipolar cells, and rod and cone photoreceptors is known as the neurosensory retina." [1]
"The retina is the only place where we can non-invasively visualize the micro-vessels in our body, thus allowing us to better understand systemic vascular health." [1]
Read “only place” as the lecturer's emphasis that retinal microvessels are readily and directly inspected in vivo during routine clinical examination.
Why this matters: When an examiner asks you to perform fundoscopy on a hypertensive or diabetic patient, they're testing whether you understand that you're looking at a live microvascular bed — the same vessels that are being damaged in the kidneys, brain, and heart.
| Structure | What to Look For | Clinical Significance |
|---|---|---|
| Optic disc | Margins (sharp vs blurred), colour (yellow-pink vs pale), cup-to-disc ratio | Blurred margin suggests disc swelling but does not by itself prove papilloedema/raised ICP; pallor suggests optic atrophy |
| Retinal vasculature | Arteries vs veins, AV crossings, calibre, tortuosity | HTN changes (silver wiring, AV nipping); diabetic changes |
| Macula lutea | Pigmented area, contains xanthophyll pigment (lutein + zeaxanthin = antioxidants) | Central vision; diabetic macular oedema threatens this area |
| Fovea centralis | Thin central pit within a capillary-free zone | Cone-dense centre for highest acuity; outer retina depends on choroidal circulation |
"The macula is the pigmented area of the retina responsible for central vision. The yellow tone is due to the presence of xanthophyll pigment (lutein and zeaxanthin), which serve as anti-oxidants." [1]
The slide emphasises that the foveal centre is thin and lacks overlying retinal capillaries; its outer retinal layers depend on the underlying choroid. [1]
How to orient the labelled fundus image: the optic disc is nasal, while the darker macula and central foveal reflex are temporal. Superior and inferior temporal vascular arcades curve around rather than cross the fovea. Macula-off retinal detachment threatens central acuity; recovery depends on duration and macular/photoreceptor damage, so “irreversible” is not automatic.
This is a classic exam question: "Why do haemorrhages look different in different conditions?"
"The morphology of the retinal hemorrhage is determined by the retinal layer." [1]
| Haemorrhage Type | Location | Morphology | Why This Shape? | Think Of... |
|---|---|---|---|---|
| Pre-retinal haemorrhage | Between posterior hyaloid and internal limiting membrane (or sub-ILM) | Boat-shaped / retrohyaloid | Blood spreads in a potential space and settles to form a horizontal fluid level | Proliferative diabetic retinopathy |
| Flame-shaped haemorrhage | Superficial nerve fibre layer (intra-retinal) | Flame/splinter | Nerve fibres in superficial layer run horizontally → blood tracks along them | Hypertensive retinopathy, retinal vein occlusion |
| Dot and blot haemorrhage | Deep retinal layers (intra-retinal) | Dot or blot | Deep layers have vertical arrangement of cells → blood pools in small round pockets | Diabetic retinopathy |
Hard exudates deposit in the outer plexiform layer of the retina, as shown in the lecture's retinal cross-section diagram. [1]
The diagrams link shape to tissue architecture: superficial blood follows horizontally oriented RNFL bundles; deeper blood is confined within more compact retinal layers; preretinal blood can spread broadly across a potential space. These are associations, not one-disease-per-shape rules.
Exam Trap: Haemorrhage Morphology
Flame-shaped haemorrhages are superficial (nerve fibre layer) and suggest hypertension or vein occlusion. Dot-and-blot haemorrhages are deep and suggest diabetic retinopathy. Pre-retinal/boat-shaped haemorrhages suggest proliferative diabetic retinopathy with new fragile vessels. The shape tells you the layer, and the layer tells you the disease.
2. Diabetic Retinopathy (DR)
"Most frequent cause of preventable blindness in working-aged adults." [1]
| Fact | Detail |
|---|---|
| Prevalence in Type 1 DM | ~80% |
| Prevalence in Type 2 DM | ~40% |
| Overall lifetime risk | ~80% amongst all diabetics |
| Trend | Increasing prevalence in recent decades |
These are the lecture's historical summary estimates from a 2010 review, not prevalence values to apply to every contemporary population. DR frequency varies greatly with diabetes duration, type, glycaemic/BP control and the population studied.
Why "preventable"? Because retinal screening, durable glycaemic/BP control and timely ophthalmic treatment reduce avoidable vision loss. Rapid large improvement in glycaemia can transiently worsen existing retinopathy in some high-risk patients, so it calls for eye monitoring—not abandonment of long-term glucose control. [15]
From both the lecture and supporting notes [1][2]:
- Duration of DM — 80% have DR after 20 years of disease
- Poor glycaemic control (HbA1c)
- Vascular comorbidities — especially hypertension, smoking
- Pregnancy — can accelerate DR progression
- Rapid implementation of tight glycaemic control — paradoxically can worsen DR transiently
The lecture explicitly states: "You won't be tested on this in MBBS IV" for the detailed pathway, but you MUST understand the broad concept because it explains every clinical sign.
Hyperglycaemia
→ Oxidative stress, AGEs, PKC activation, inflammation, sorbitol accumulation
→ Vascular endothelial dysfunction
→ Two consequences:
1. ↑Vascular permeability → leakage → oedema, hard exudates
→ DIABETIC MACULAR OEDEMA
2. Retinal ischaemia → VEGF/IGF release
→ Retinal neovascularization
→ PROLIFERATIVE DRFirst principles explanation:
- Chronic hyperglycaemia damages the endothelial cells lining retinal capillaries through multiple biochemical pathways (oxidative stress, advanced glycation end-products, protein kinase C activation, sorbitol accumulation via the polyol pathway)
- This endothelial damage causes two problems simultaneously:
- Leaky vessels (↑vascular permeability) → fluid and lipoproteins leak into the retina → retinal oedema and hard exudates
- Blocked vessels (microthrombosis, capillary occlusion) → retinal ischaemia → the ischaemic retina screams for help by releasing VEGF → new (but fragile, abnormal) blood vessels grow = neovascularization
"Intraretinal hemorrhages — usually visually insignificant" [1] "Hard exudates — lipoproteins following partial/complete resorption of retinal edema" [1] "Cotton wool spots — focal areas of ischemic infarcts" [1] "Intraretinal microvascular abnormalities (IRMA) — pre-neovascularization retinal vascular abnormalities" [1]
| Sign | What It Is | Why It Happens | Layer/Significance |
|---|---|---|---|
| Microaneurysms | Tiny outpouchings of capillary walls | Pericyte loss → weakened capillary wall | Earliest clinical sign of DR |
| Dot-and-blot haemorrhages | Small round intraretinal haemorrhages | Microaneurysm rupture in deep retinal layers | Deep layer → round shape |
| Hard exudates | Yellow, waxy deposits with sharp margins | Lipoprotein residue after retinal oedema partially resorbs | Indicate vascular leakage; concerning if near macula |
| Cotton wool spots | White, fluffy patches | Focal ischaemic infarcts of retinal nerve fibre layer → axoplasmic flow stasis → swollen axon tips | Indicate retinal ischaemia |
| IRMA | Abnormal shunt vessels within the retina | Represent pre-neovascularization changes; dilated capillary channels | Indicate severe NPDR → about to tip into PDR |
| Venous beading | Irregular calibre of retinal veins | Retinal ischaemia affecting venous wall | Predictor of progression to PDR |
2.5 The Two Sight-Threatening Conditions
"Two major sight-threatening conditions in diabetic retinopathy: (1) Diabetic macular oedema, (2) Proliferative diabetic retinopathy." [1]
This is the critical clinical distinction: DMO can occur at ANY stage of DR (even mild NPDR), while PDR represents advanced ischaemia-driven neovascularization.
Pathophysiology: ↑vascular permeability pathway → fluid accumulation in the macular area → thickened retina → reduced central visual acuity.
Clinical examination findings:
- Hard exudates near or at the macula
- Retinal oedema (thickened retina, best seen on OCT)
Why DMO matters most for vision: The macula is responsible for central vision (reading, driving, recognizing faces). Even mild oedema here causes disproportionate visual impairment compared to peripheral retinal changes.
Investigation: Optical Coherence Tomography (OCT) — cross-sectional imaging of retinal layers showing increased macular thickness and fluid pockets (the lecture notes "you won't be tested on this" but understand the concept) [1].
Reading the three OCT slides:
- A normal macula has an orderly layered reflectivity pattern and a central foveal depression.
- The 20/40 example shows small dark intraretinal cystic spaces and loss/distortion of the normal contour.
- The 20/200 example shows much greater thickening with large cystoid spaces; punctate hyperreflective foci can correspond to lipid/exudative material. The paired fundus photograph may understate oedema that is conspicuous in cross-section.
- VA does not map perfectly to thickness alone; foveal involvement, ischaemia and photoreceptor integrity also matter.
Treatment (marked as not testable in MBBS IV, but know the principles):
- Intravitreal anti-VEGF is first-line for most centre-involving DMO with impaired VA.
- Macular laser remains useful in selected non-centre-involving disease or when chosen by the retina service.
- Intravitreal steroid is an alternative/adjunct in selected eyes, with cataract and IOP risks.
The three items on the slide are options, not a universal sequence. [15]
"Diabetic macular oedema is the commonest cause of vision loss in DM patients." [2]
Pathophysiology: Retinal ischaemia → VEGF/IGF release → growth of new vessels (neovascularization).
"Characterized by the presence of new vessels — thin (hair-like), pre-retinal, blind-ending." [1]
Why new vessels are dangerous: These new vessels are:
- Fragile — they lack the structural integrity of normal vessels
- Pre-retinal — they grow on the retinal surface into the vitreous cavity
- Leaky — they allow fluid/blood to escape (fluorescein angiography shows leakage = hallmark of unstable new vessels)
Reading the fundus and angiography pair: normal retinal vessels remain sharply outlined. Neovascular tufts appear as fine, irregular preretinal loops—on or within one disc diameter of the disc (NVD) or elsewhere (NVE)—and become increasingly bright and fuzzy on later fluorescein frames because dye leaks beyond the vessel boundary. Leakage helps distinguish active new vessels from mature non-leaking collaterals.
Complications of PDR (cascade of worsening):
| Complication | Mechanism | Visual Impact |
|---|---|---|
| 1. Pre-retinal haemorrhage | Fragile new vessels bleed between retina and vitreous | Boat-shaped haemorrhage, may obscure vision |
| 2. Vitreous haemorrhage | Blood fills the vitreous cavity | Sudden painless loss of vision ("red out") |
| 3. Fibrovascular proliferation | Fibrous tissue grows along with new vessels | Epiretinal membranes tether retina/vitreous; OCT shows a hyperreflective tractional complex |
| 4. Tractional retinal detachment | Fibrovascular membranes contract, producing a concave/tented elevation without a primary retinal break | Threatens the macula and central vision |
| 5. Neovascular glaucoma | Neovascularization of iris (rubeosis iridis) → new vessels + fibrous tissue block aqueous drainage angle | Painful eye with very high IOP → optic nerve damage |
High Yield: Why Rubeosis Iridis Causes Glaucoma
Severe retinal ischaemia raises intraocular VEGF, which promotes new vessels over the iris surface (rubeosis iridis) and angle. A fibrovascular membrane obstructs the trabecular meshwork and later contracts, producing peripheral anterior synechiae and secondary angle closure. On the slide, look for abnormal fine vessels at the pupillary margin/iris surface rather than normal radial iris markings. [1][2]
Treatment of PDR (marked as not testable in MBBS IV, but important concepts):
- Panretinal photocoagulation (PRP) — destroys peripheral ischaemic retina → reduces VEGF production → regression of new vessels
- Anti-VEGF injection — an effective alternative/adjunct in selected PDR, but adherence and tractional anatomy matter; rapid fibrovascular contraction (“crunch”) is a specialist consideration, not a simple absolute rule
- Vitrectomy — for non-resolving vitreous haemorrhage, tractional retinal detachment, tractional-rhegmatogenous retinal detachment
| Complication | Mechanism |
|---|---|
| Cataract | Activation of polyol/pentose pathway → sorbitol accumulation within lens → osmotic swelling → opacification |
| CN III, IV, VI palsies | Mononeuritis multiplex from vasa nervorum ischaemia |
| Neovascular glaucoma | Rubeosis iridis (see above) |
| Fluctuating refractive errors | Osmotic lens swelling with glucose fluctuations |
| ↓ Tear production | Autonomic neuropathy |
3. Hypertensive Retinopathy
"Not a disease, just a grading system for hypertension control." [1]
Treat that slide phrase as teaching shorthand, not a literal definition. Hypertensive retinopathy is retinal target-organ involvement associated with hypertension. Chronic arteriolosclerotic signs reflect cumulative vascular injury; haemorrhages, cotton-wool spots, hard exudates and disc swelling can signal an acutely severe microvascular process. A grading system describes the findings but does not replace BP measurement or assessment of brain, heart, aorta and kidneys.
The lecture presents the following simplified “modified Scheie” table. [1]
| Grade | Findings | What's Happening |
|---|---|---|
| Grade 0 | No changes | Normal |
| Grade 1 | Barely detectable generalised arteriolar narrowing | Early vasoconstrictive change |
| Grade 2 | Obvious narrowing with focal irregularity | More definite arteriolar change; AV-crossing change may coexist |
| Grade 3 | Grade 2 + retinal haemorrhages and/or exudates | Blood–retina barrier failure and retinal ischaemia |
| Grade 4 | Grade 3 + optic-disc swelling | Severe hypertensive retinal/optic-nerve target-organ injury |
The slide blends hypertensive and arteriosclerotic signs. In the original Scheie approach they are graded separately: narrowing is the hypertensive component, while broadening of the arteriolar light reflex, copper/silver wiring and AV-crossing change describe sclerosis. Silver wiring is advanced wall opacity, not a reliable synonym for barely detectable Grade 1 narrowing. Other classification systems use different labels.
Critical Definition: Malignant Hypertension
The lecture uses >180/120 mmHg + end-organ damage as its rule. The decisive concept is new or worsening acute target-organ damage, not the BP number alone. Advanced retinal haemorrhages/exudates or disc swelling can provide ocular evidence, but a hypertensive emergency can also be diagnosed from encephalopathy, stroke, acute coronary syndrome, pulmonary oedema, aortic dissection, acute kidney injury or pregnancy-related disease without Grade 3 retinopathy. Conversely, a very high number without acute organ injury is not automatically an emergency. [17]
“Malignant hypertension” is an older/separate term used variably for severe hypertension with advanced microvascular injury; do not make the unsafe claim that Grade 3 retina is mandatory for every hypertensive emergency. Silver wiring/AV nicking alone generally suggest chronic sclerosis rather than acute retinal injury.
3.2 Individual Signs Explained
"Due to arteriosclerosis, the muscle wall of the arteries become thicker and more light-reflective." [1]
Normal retinal arterioles have relatively transparent walls, so the central light reflex is narrow. With sclerosis, wall thickening/opacification broadens the reflex: classically copper wiring first and silver wiring when the blood column is largely obscured. The photograph highlights an abnormally pale reflective arteriole.
"At areas where the artery and vein cross, and also within the optic nerve canal, the retinal arteries and veins share a common adventitial sheath. Therefore within a finite space, the increasingly thickened artery may compress the vein." [1]
Why this matters clinically: AV nipping is the anatomical basis for branch retinal vein occlusion — the thickened artery physically compresses the vein at the crossing point, causing venous stasis → thrombosis → occlusion. This directly links Section 3 to Section 4 of this lecture.
"Prolonged/severe venous obstruction, leading to hemorrhage and retinal ischemia." [1]
The slide attributes these to “venous obstruction,” but the more useful hypertensive mechanism is acute arteriolar injury → ischaemia and blood–retina barrier failure. Cotton-wool spots are RNFL microinfarcts; flame haemorrhages track within the RNFL; hard exudates are lipid residues from leakage. Similar lesions occur in diabetes, vein occlusion and other retinopathies, so distribution and vascular context matter.
The slide labels this photograph “papilloedema,” but that word should be reserved for disc swelling caused by raised intracranial pressure. [1]
In severe hypertension, disc swelling can be hypertensive optic neuropathy from vascular leakage/ischaemia and does not require raised ICP. The image also shows haemorrhages, cotton-wool spots/hard exudates and a macular-star pattern. If raised ICP is independently present, papilloedema is possible; fundoscopy alone does not establish the mechanism. In either case, severe BP with acute visual, neurologic or other target-organ injury requires emergency assessment.
From the supporting HTN lecture [4], hypertension causes end-organ damage to 5 regions:
| Organ | History | Examination/Investigation |
|---|---|---|
| Brain | Headache, vertigo, TIAs, sensory/motor deficit | Carotid bruit, neurological deficits |
| Eyes | Impaired vision → ischaemic retinopathy | Fundoscopic abnormalities, retinal artery narrowing |
| Heart | Palpitations, chest pain, SOB, ankle swelling | LVH, S3, rales, oedema |
| Kidney | Thirst, polyuria, nocturia | ↑Creatinine, proteinuria |
| Peripheral vessels | Claudication | Absent pulses, bruits |
4. Retinal Vein Occlusion (RVO)
"Second most common sight-threatening vascular disorder." [1] "Affects about 1% general population; 51% > 65 years of age." [1]
These are the lecture's historical epidemiological figures. Prevalence depends on age and population; the durable point is that RVO is common, predominantly affects older adults and should trigger cardiovascular/ocular risk assessment.
| Type | Proportion | Presentation |
|---|---|---|
| Branch RVO (BRVO) | 69.5% | Visual field loss or may be asymptomatic |
| Central RVO (CRVO) | 30.5% | Presents with vision loss |
The 69.5/30.5 split is the cited lecture dataset, not a universal ratio. BRVO produces haemorrhage/venous dilation in a wedge-shaped sector drained by the affected branch and may spare the fovea. CRVO affects all four quadrants with widespread dilated tortuous veins and haemorrhages—the classic “blood-and-thunder” pattern—and central vision falls particularly when macular oedema/ischaemia is present.
The pathogenesis follows directly from the hypertensive retinopathy discussion and is framed around Virchow's triad [1]:
| Virchow's Triad Component | Mechanism in RVO |
|---|---|
| Endothelial injury | Shear stress at AV crossing where thickened artery compresses the vein |
| Abnormal blood flow | Venous compression → stasis / turbulent flow |
| Hypercoagulability | Systemic prothrombotic states (DM, APLS, malignancy) |
These three factors converge to produce a thrombus within the retinal vein:
- Hypertension → arteriosclerosis → thickened retinal artery
- At AV crossing points (shared adventitial sheath), the artery compresses the vein → endothelial injury (shear stress) + abnormal blood flow (stasis)
- Venous compression → stasis → thrombosis → vein occlusion
- Upstream: venous congestion → haemorrhages, oedema
- Downstream: decreased blood flow → hypoxia → HIFs → VEGF → potential neovascularization
The slide labels hypertension as present in “95% of all cases”; regard this as a historical case-control teaching figure, not a universal prevalence. [1]
| Risk Factor | Mechanism |
|---|---|
| Hypertension | Major systemic association; arteriolar sclerosis/AV-crossing injury is especially relevant to BRVO |
| Diabetes | Associated particularly with CRVO and shared vascular risk burden |
| Ocular hypertension / open-angle glaucoma | Important ocular association, especially for CRVO |
| Hypercoagulable state | ↑Tendency for thrombosis (e.g. APLS, malignancy) |
| Age, dyslipidaemia, cardiovascular disease | Shared vascular/endothelial risk |
Exam Pearl: HTN is the #1 Risk Factor for RVO
If an exam question presents acute monocular visual loss plus dilated tortuous veins and sectoral or four-quadrant retinal haemorrhages, think RVO. Hypertension is a major association, but assess BP, lipids, glucose/diabetes, glaucoma/IOP and cardiovascular risk rather than memorising 95% as a universal fact. Broader thrombophilia/inflammatory investigation is targeted to young, bilateral, recurrent or otherwise atypical cases. [16,18]
"Dilated and tortuous veins, flame-shaped hemorrhages, cotton wool spots, hard exudates." [1]
The fundoscopic picture of RVO is dramatic — sometimes described as "blood and thunder" fundus in CRVO:
- Dilated, tortuous veins — because outflow is blocked
- Flame-shaped haemorrhages — blood leaks in the nerve fibre layer (superficial)
- Cotton wool spots — ischaemic infarcts
- Hard exudates — lipoprotein leakage from damaged vessels
Also look for disc oedema and macular oedema. OCT quantifies macular fluid; fluorescein angiography helps map non-perfusion and leakage when haemorrhage does not obscure the view.
"May improve spontaneously." [1]
The lecture demonstrates one serial case improving from VA 20/200 → 20/50 → 20/30 as haemorrhages clear. Read it as an example of possible evolution, not a prediction for every RVO; prognosis depends on macular oedema/ischaemia, initial VA, occlusion type and neovascular complications. [1]
- Development of collaterals — bypass vessels may form
- Recanalization of thrombus — the clot may resolve
- The slide states that 50% develop optociliary shunt vessels; this is a lecture-specific historical estimate [1]
- Progression with ischaemic complications — if collaterals are insufficient:
- Neovascular glaucoma (same mechanism as PDR: ischaemia → VEGF → rubeosis iridis)
- Retinal neovascularization
Collateral versus neovascular vessel (the paired colour/angiography slides): optociliary shunt vessels are enlarged mature collateral channels on/around the disc that reroute venous blood and typically do not show the profuse late leakage of NVD. New vessels are fine, disorganised and leaky on fluorescein angiography. This distinction prevents a useful collateral from being mislabeled as proliferative disease.
"Identify & treat risk factors. Treat complications (if visual impairment present). Intravitreal anti-VEGF agents injection. Pan-retinal or sectoral laser photocoagulation." [1]
| Step | Action | Why |
|---|---|---|
| 1 | Identify and treat risk factors | Check/control BP, glucose/diabetes, lipids and glaucoma/IOP; address cardiovascular risk |
| 2 | Treat macular oedema | Intravitreal anti-VEGF is first-line for centre-involving oedema; steroid is an alternative in selected eyes |
| 3 | Detect neovascular complications | Examine retina, iris/pupillary margin and angle; risk is higher in ischaemic disease |
| 4 | Laser when indicated | Sectoral laser for BRVO neovascularisation; PRP for anterior/retinal neovascularisation in ischaemic CRVO—not routine laser merely because VA is reduced |
There is no treatment that “unblocks” the vein reliably. Management treats macular oedema/neovascular sequelae and the patient's systemic risk; follow-up intensity is determined by ischaemic risk. [16]
5. Beyond the Retina: Other Ocular Manifestations of Systemic Disease
While the lecture focuses on retinal manifestations, the broader topic of "ocular manifestations of systemic disease" is frequently tested. Integrating from supporting sources:
| Feature | Detail |
|---|---|
| Pathogenesis | Anti-TSHr antibodies → bind TSHr on orbital fibroblasts → cytokine release → adipogenesis + GAG accumulation → ↑retroocular tissue volume |
| Clinical: Lid signs | Lid retraction, lid lag, lagophthalmos |
| Clinical: Orbital signs | Proptosis/exophthalmos, ophthalmoplegia (IR > MR > SR > LR) |
| Sight-threatening | Dysthyroid compressive optic neuropathy (↓colour vision/VA, RAPD if asymmetric, field defect; disc may be normal or swollen) |
| Risk factors | Smoking (2.22× risk), RAI treatment, higher TRAb titres |
From past paper [7] — Bull's eye maculopathy:
- HCQ accumulates in retinal pigment epithelium → toxic maculopathy
- Presents as bilateral progressive blurring of vision
- Bull's eye appearance on fundoscopy: ring of depigmentation around the fovea
- Irreversible once established
- Screening: annual eye check after 5 years of HCQ use [8]
- Corneal deposits from HCQ are reversible (distinguish from maculopathy)
| Disease | Ocular Manifestations |
|---|---|
| Rheumatoid Arthritis | 2° Sjögren's, peripheral ulcerative keratitis (PUK), episcleritis, scleritis, uveitis [10] |
| Seronegative SpA (e.g. AS) | Anterior uveitis (most classic), conjunctivitis (Reiter's syndrome triad) [10] |
| Behçet's Disease | Anterior/posterior/panuveitis, retinal vasculitis [10] |
| Giant Cell Arteritis | Anterior ischaemic optic neuropathy (AAION), central retinal artery occlusion (CRAO) [10] |
| IBD | Uveitis (usually anterior), episcleritis, scleritis, iritis [11] |
| Sarcoidosis | Uveitis (anterior > posterior), lacrimal gland involvement [12] |
- Roth's spots: yellow-centred haemorrhages (septic emboli to retina) [14]
Exam Intelligence
- Fundoscopy image → identify signs → classify DR stage / HTN grade
- "A 55-year-old diabetic presents with sudden painless loss of vision" → vitreous haemorrhage from PDR
- "Describe the retinal findings in this patient with poorly controlled hypertension" → Modified Scheie grading
- "What is the most important modifiable systemic association for retinal vein occlusion?" → Hypertension (the slide's 95% is not universal)
- "Name two sight-threatening conditions in diabetic retinopathy" → DMO + PDR
- "A patient on HCQ for 8 years develops bilateral progressive blurring of vision" → Bull's eye maculopathy [7]
| Trap | Correct Answer |
|---|---|
| Confusing flame-shaped (superficial/HTN) with dot-blot (deep/DM) haemorrhages | Layer determines morphology |
| Repeating “hypertensive retinopathy is not a disease” literally | It is retinal target-organ involvement; a grading system describes chronic versus acute signs |
| Assuming DMO only occurs in advanced DR | DMO can occur at any stage |
| “Hypertensive emergency requires Grade 3 retina” | Acute target-organ injury defines the emergency; advanced retinal findings are one possible organ manifestation |
| Calling all disc swelling "papilloedema" | Papilloedema specifically = disc swelling due to ↑ICP; papillitis = inflammatory disc swelling with vision loss |
- "Diabetic retinopathy is the most frequent cause of preventable blindness in working-aged adults."
- "The two sight-threatening conditions in DR are: (1) diabetic macular oedema, (2) proliferative diabetic retinopathy."
- "In the lecture's modified Scheie scale, Grade 3 adds retinal haemorrhages/exudates to arteriolar narrowing; Grade 4 adds optic-disc swelling."
- "Hypertension is a major modifiable systemic association for retinal vein occlusion; the slide's 95% figure is dataset-specific."
High Yield Summary
- Retinal haemorrhage shape localises its layer: flame/splinter = superficial RNFL; dot/blot = deeper retina; boat-shaped = preretinal potential space.
- The two sight-threatening DR pathways are permeability and ischaemia: DMO can occur at any stage; PDR is defined by new vessels and can cause haemorrhage, fibrovascular traction and neovascular glaucoma.
- Read images mechanistically: OCT shows fluid/traction in cross-section; fluorescein leakage identifies active unstable new vessels; mature collaterals usually do not leak profusely.
- Hypertensive retinal signs span chronic sclerosis and acute injury: narrowing/wiring/AV nicking are not equivalent to haemorrhages, exudates or disc swelling. Hypertensive emergency is defined by acute target-organ damage, not a mandatory retinal grade.
- RVO distribution distinguishes branch from central disease: BRVO is sectoral; CRVO affects all quadrants. Manage systemic/ocular risks, treat macular oedema with intravitreal therapy and treat neovascularisation with appropriate laser/adjuncts.
- Terminology matters: optic-disc swelling in severe hypertension is not automatically papilloedema; papilloedema specifically implies raised ICP.
Active Recall - Ocular Manifestations of Systemic Disease
[1] Lecture slides: CFB (OPHTH02) Ocular Manifestations of Systemic Disease.pdf [2] Senior notes: Ryan Ho Endocrine.pdf (Section: Diabetic Retinopathy and Eye Complications) [3] Senior notes: Block A - Deterioration of eyesight in a diabetic patient_ diabetic complications.pdf [4] Senior notes: Block A - High blood pressure_ hypertension.pdf (Target organ damage section) [5] Senior notes: Ryan Ho Opthalmology.pdf (Section 7.1: Dysthyroid Eye Disease) [6] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Graves' ophthalmopathy) [7] Past papers: 2021 Fourth Summative Assessment MCQ.pdf (Question 13) [8] Senior notes: Maksim Medicine Notes.pdf (SLE section, HCQ monitoring) [9] Senior notes: Block A - Facial rash and painful fingers_ SLE.pdf [10] Senior notes: Ryan Ho Opthalmology.pdf (Section 7.2: Rheumatological Disease and the Eye) [11] Senior notes: Block A - Chronic diarrhoea_ irritable bowel syndrome and inflammatory bowel disease.pdf (Extraintestinal manifestations) [12] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Sarcoidosis section) [13] Senior notes: Ryan Ho GI.pdf (Wilson's disease section) [14] Senior notes: Ryan Ho Fundamentals.pdf (Fundoscopy section) [15] American Diabetes Association. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026. https://doi.org/10.2337/dc26-S012 [16] Royal College of Ophthalmologists. Retinal Vein Occlusion Guidelines. 2022. https://www.rcophth.ac.uk/resources-listing/retinal-vein-occlusion-rvo-guidelines/ [17] American Heart Association. Management of Elevated Blood Pressure in the Acute Care Setting. 2024. https://professional.heart.org/en/science-news/management-of-elevated-blood-pressure-in-the-acute-care-setting [18] American Academy of Ophthalmology EyeWiki. Retinal Vein Occlusion. https://eyewiki.aao.org/Retinal_Vein_Occlusion
CFB OG04 Menstrual Disorders
Menstrual disorders are abnormalities in the frequency, duration, amount, or regularity of menstrual bleeding, including conditions such as amenorrhea, oligomenorrhea, menorrhagia, dysmenorrhea, and premenstrual syndrome.
CFB PAE01 Paediatric History Taking
Paediatric history taking is the systematic process of gathering a child's clinical information—including presenting complaint, history of present illness, birth history, developmental milestones, immunisation status, feeding/nutrition, and family/social history—from the parent or caregiver to guide diagnosis and management.